🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is designed to investigate the effects of rilapladib on biomarker...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-10-01
Trial ID
NCT01428453
Treatments Being Tested
This study is designed to assess whether inhibition of plasma Lp-PLA2 activ...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-07
Trial ID
NCT01745458
A study in patients with atherosclerosis to assess safety, effect and PK of...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-11
Trial ID
NCT00695305
Treatments Being Tested
Rilapladib is a potent and selective inhibitor of lipoprotein associated ph...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-10
Trial ID
NCT02130661
Treatments Being Tested
This will be an open-label, single dose, single period study. Approximately...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-09
Trial ID
NCT01750827
Treatments Being Tested
The purpose of this study is to compare the effects of repeat doses of SB-6...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-10
Trial ID
NCT00387257
Treatments Being Tested